Real-World Treatment Effectiveness of Disease-Modifying Antirheumatic Drugs by Serostatus Among Patients With Rheumatoid Arthritis.

Yinzhu JinJun LiuRishi J DesaiSeoyoung C Kim

Published in: ACR open rheumatology (2023)

In this real-world cohort study, seropositive and seronegative patients with RA had similar 1-year treatment effectiveness after initiating a bDMARD/JAKi.

Keyphrases

randomized controlled trial
rheumatoid arthritis
systematic review
systemic lupus erythematosus
disease activity
rheumatoid arthritis patients
systemic sclerosis
ankylosing spondylitis
interstitial lung disease